journal article·2022-01Open access

Soluble ICAM‐1 a Pivotal Communicator between Tumors and Macrophages, Promotes Mesenchymal Shift of Glioblastoma

Ki‐Chun Yoo, Jae‐Hyeok Kang, Mi‐Young Choi, Yongjoon Suh, Yi Zhao, Min‐Jung Kim, Jong Hee Chang, Jin‐Kyoung Shim, Seon‐Jin Yoon, Seok‐Gu Kang, Su‐Jae Lee

Advanced Science· Volume 9· Issue 2

Abstract

Abstract Despite aggressive clinical treatment, recurrence of glioblastoma multiforme (GBM) is unavoidable, and the clinical outcome is still poor. A convincing explanation is the phenotypic transition of GBM cells upon aggressive treatment such as radiotherapy. However, the microenvironmental factors contributing to GBM recurrence after treatment remain unexplored. Here, it is shown that radiation‐treated GBM cells produce soluble intercellular adhesion molecule‐1 (sICAM‐1) which stimulates the infiltration of macrophages, consequently enriching the tumor microenvironment with inflammatory macrophages. Acting as a paracrine factor, tumor‐derived sICAM‐1 induces macrophages to secrete wingless‐type MMTV integration site family, member 3A (WNT3A), which promotes a mesenchymal shift of GBM cells. In addition, blockade of either sICAM‐1 or WNT3A diminishes the harmful effect of radiation on tumor progression. Collectively, the findings indicate that cellular crosstalk between GBM and macrophage through sICAM‐1‐WNT3A oncogenic route is involved in the mesenchymal shift of GBM cells after radiation, and suggest that radiotherapy combined with sICAM‐1 targeted inhibition would improve the clinical outcome of GBM patients.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Glioma Diagnosis and Treatment · Neuroinflammation and Neurodegeneration Mechanisms · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Life Science Research Institute for Natural Sciences Hanyang University Seoul 04763 Korea

Department of Lymphoma and Myeloma Division of Cancer Medicine Center for Cancer Immunology Research The University of Texas MD Anderson Cancer Center Houston TX 77030 USA

Laboratory of Radiation Exposure & Therapeutics National Radiation Emergency Medical Center Korea Institute of Radiological and Medical Sciences Seoul 01812 Korea

Department of Neurosurgery Brain Tumor Center Severance Hospital Yonsei University College of Medicine Seoul 03722 Korea

Funding

National Research Foundation of Korea

References (32)

Show source-provided references
1. 10.1056/NEJMoa04333010.1056/NEJMoa043330 ↗
2. 10.1016/j.ccr.2006.02.01910.1016/j.ccr.2006.02.019 ↗
3. 10.1073/pnas.132101411110.1073/pnas.1321014111 ↗
4. 10.1016/j.ccr.2013.08.00110.1016/j.ccr.2013.08.001 ↗
5. 10.2174/13816120878574022510.2174/138161208785740225 ↗
6. 10.1016/S1734-1140(09)70004-010.1016/S1734-1140(09)70004-0 ↗
7. 10.1161/ATVBAHA.108.16962310.1161/ATVBAHA.108.169623 ↗
8. Ogawa Y. · Clin. Cancer Res. · 1998 · 4 · 31
9. 10.1002/ijc.2806610.1002/ijc.28066 ↗
10. 10.1245/s10434-011-2029-010.1245/s10434-011-2029-0 ↗
11. 10.1038/onc.2009.25210.1038/onc.2009.252 ↗
12. 10.1038/onc.2014.46610.1038/onc.2014.466 ↗
13. 10.1007/BF0175638110.1007/BF01756381 ↗
14. 10.4049/jimmunol.140013510.4049/jimmunol.1400135 ↗
15. 10.1002/1097-0215(20001201)88:5<766::AID-IJC13>3.0.CO;2-Y10.1002/1097-0215(20001201)88:5<766::AID-IJC13>3.0.CO;2-Y ↗
16. 10.1038/sj.onc.120490310.1038/sj.onc.1204903 ↗
17. 10.1016/j.immuni.2013.10.00310.1016/j.immuni.2013.10.003 ↗
18. 10.1371/journal.pone.004333910.1371/journal.pone.0043339 ↗
19. 10.1038/ncb309010.1038/ncb3090 ↗
20. 10.1016/j.neuroscience.2008.06.05210.1016/j.neuroscience.2008.06.052 ↗
21. 10.1155/2013/48691210.1155/2013/486912 ↗
22. 10.3892/or.2016.466010.3892/or.2016.4660 ↗
23. 10.1016/j.semcancer.2019.07.02810.1016/j.semcancer.2019.07.028 ↗
24. 10.1002/jlb.66.6.87610.1002/jlb.66.6.876 ↗
25. 10.1038/nn.418510.1038/nn.4185 ↗
26. 10.1038/nrc261810.1038/nrc2618 ↗
27. 10.1016/0140-6736(91)90077-310.1016/0140-6736(91)90077-3 ↗
28. 10.1212/WNL.44.12.236710.1212/WNL.44.12.2367 ↗
29. 10.1007/s11481-012-9359-y10.1007/s11481-012-9359-y ↗
30. 10.1158/0008-5472.CAN-12-095310.1158/0008-5472.CAN-12-0953 ↗
31. 10.1007/s00401-007-0243-410.1007/s00401-007-0243-4 ↗
32. 10.1007/s00381-012-1988-110.1007/s00381-012-1988-1 ↗